Drug Profile
Research programme: siDNA anticancer therapeutics - Valerio Therapeutics
Alternative Names: DT02; siDNA - Valerio Therapeutics; Small inhibitory DNA - Valerio Therapeutics; XbaitLatest Information Update: 08 Sep 2023
Price :
$50
*
At a glance
- Originator DNA Therapeutics
- Developer Valerio Therapeutics
- Class
- Mechanism of Action DNA repair inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Solid-tumours in France (Intratumoural)
- 05 Dec 2011 Preclinical development is ongoing in France